Nuo Therapeutics, Inc.
AURXOTCCIK 1091596HealthcareFiscal year ends Dec 31
Reports and events: 270 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-032242 |
| 2026-08-1711:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-028109 |
| 2026-08-1421:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-028053 |
| 2026-06-0315:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001674752-26-000002 |
| 2026-06-0321:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-019199 |
| 2026-05-1421:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017116 |
| 2026-05-1421:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017104 |
| 2026-03-3021:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010360 |
| 2026-01-2623:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-26-002120 |
| 2026-01-2621:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-002078 |
| 2025-12-1716:09 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-038091 |
| 2025-10-3020:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-032437 |
| 2025-10-3017:10 ET | DEF 14A | Proxy statementPeriod 2025-12-16 | 0001437749-25-032357 |
| 2025-10-1012:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001437749-25-030813 |
| 2025-07-3113:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-024043 |
| 2025-05-1520:32 ET | 8-K | 1.01 Entry into a material agreement | 0001437749-25-017214 |
| 2025-04-3013:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-013653 |
| 2025-04-0114:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-010379 |
| 2024-11-1213:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034325 |
| 2024-09-1920:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-029602 |
| 2024-08-1212:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025952 |
| 2024-06-2720:15 ET | 8-K | 8.01 Other events | 0001437749-24-021407 |
| 2024-06-1120:26 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-24-019961 |
| 2024-05-2112:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-017754 |
| 2024-05-1521:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-017125 |
| 2024-04-1921:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-012587 |
| 2024-04-1621:26 ET | 8-K | 7.01 Regulation FD disclosure | 0001437749-24-012214 |
| 2023-12-2019:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-23-034986 |
| 2023-12-2014:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-23-034949 |
| 2023-11-2021:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-032632 |
| 2023-08-1420:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-023710 |
| 2023-08-0320:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-23-021942 |
| 2023-05-1520:56 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-014639 |
| 2023-04-1801:32 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001437749-23-010489 |
| 2023-04-1722:08 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-010351 |
| 2022-12-0521:30 ET | 8-K | 5.07 Shareholder vote results | 0001437749-22-028414 |
| 2022-11-0421:25 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001437749-22-026082 |
| 2022-11-0421:19 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001437749-22-026078 |
| 2022-10-2012:33 ET | DEF 14A | Proxy statementPeriod 2022-12-02 | 0001437749-22-024416 |
| 2022-09-3020:01 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001437749-22-023298 |
| 2022-08-3012:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-021470 |
| 2022-08-1017:28 ET | 10-Q/A | Quarterly report, amendedPeriod 2022-06-30 | 0001437749-22-019741 |
| 2022-08-0820:48 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001437749-22-019392 |
| 2022-07-0512:02 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-22-016504 |
| 2022-07-0512:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-22-016503 |
| 2022-07-0512:01 ET | SC 13D | Ownership report, active investor | 0001437749-22-016502 |
| 2022-06-2812:30 ET | 8-K | 8.01 Other events | 0001437749-22-016051 |
| 2022-05-1620:38 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001437749-22-012650 |
| 2022-05-0212:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-22-010347 |
| 2022-04-1521:14 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001437749-22-009050 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.